Allergan Patent Deal Is No Sham, Tribe Tells PTAB
A Native American tribe that acquired patents for Allergan's blockbuster eye drug Restasis is sharply criticizing generic-drug makers for questioning its sovereign immunity from Patent Trial and Appeal Board proceedings, saying...To view the full article, register now.
Already a subscriber? Click here to view full article